No Carolina / NY / Florida
Ph: 561.316.3330

spot_img

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment

The new Roden ADA Kit expedites bioanalysis by removing the need for assay development and optimization across molecules to provide robust, reproducible, reliable data from nanoliter sample volumes. This is beneficial when ADA assessment is evaluated in preclinical animal models where sample volume may be limited.

AAOS Comments on Request for Information for Episode-Based Payment Model

Summation

  • As leaders in payment model transformation, the AAOS is well-positioned to ensure that changes to the way hospitals and physicians are paid for their services ultimately provides value to Medicare beneficiaries and their families, while reducing the administrative burden on the healthcare system,” wrote AAOS President Kevin J.
  • Last week the American Association of Orthopaedic Surgeons (AAOS) submitted comments to the Center for Medicare and Medicaid Innovation (CMMI) in response to a request for information they released in July regarding the development of Episode-Based Payment Models (CMS-5540-NC).
  • Medicaid Services (CMS) to consider the impact that interoperability, multi-payer alignment of measures, and administrative burden have on the ability of physicians to successfully participate in alternative payment models.

Last week the American Association of Orthopaedic Surgeons (AAOS) submitted comments to the Center for Medicare and Medicaid Innovation (CMMI) in response to a request for information they released in July regarding the development of Episode-Based Payment Models (CMS-5540-NC).

In its letter, AAOS expressed their support for engaging physicians in the design and implementation of alternative payment models and urged the Centers for Medicare & Medicaid Services (CMS) to consider the impact that interoperability, multi-payer alignment of measures, and administrative burden have on the ability of physicians to successfully participate in alternative payment models.

As a thought leader in reducing the complexities of value-based care and as clinical experts delivering high-value, patient-centered musculoskeletal care, AAOS shared their insights and recommendations which include:

Expanding alternative payment model (APM) episodes beyond 30 days, and encouraging the agency to consider episodes longer than 90 days
Only considering voluntary models with participation incentives– as a mandatory model would be in the disinterest of collaborative, patient-centered care
Ensuring that barriers, such as interoperability, multi-payer alignment of measures, and administrative burden are resolved in future models
Finding an approach that allows downstream risk sharing with orthopaedic surgeons
Exploring a pilot program for the management of chronic and prevalent conditions by orthopaedic surgeons

In July, AAOS and several physician organizations, requested an extension to the proposal’s 30-day comment period. While the request was denied by CMMI, the agency agreed to meet with AAOS for further discussions.

“The AAOS is excited to partner with CMS and offer our expertise based on our extensive experience with the design, implementation, and evaluation of value-based payment models. As leaders in payment model transformation, the AAOS is well-positioned to ensure that changes to the way hospitals and physicians are paid for their services ultimately provides value to Medicare beneficiaries and their families, while reducing the administrative burden on the healthcare system,” wrote AAOS President Kevin J. Bozic, MD, MBA, FAAOS.

Read the full letter here.

 

 

SonoVascular Enters Into Strategic Collaboration with Lantheus Holdings | for Use of Microbubbles in Combination with SonoThrombectomy™ System for Treatment of Venous Thromboembolism

"SonoVascular is honored to have the opportunity to partner with Lantheus, a leader in microbubble development," said Daniel Estay, Founder and Chief Executive Officer of SonoVascular. "Our SonoThrombectomy System, combined with Lantheus' microbubbles, is designed to provide a true, next-generation solution for the treatment of DVT and PE that overcomes the drawbacks associated with catheter-based thrombectomy and thrombolysis devices."

Anaut Announces Japanese Regulatory Approval of AI-Powered Surgical Visualization Tool, Eureka α

Eureka α utilizes state-of-the-art AI to analyze real-time video from laparoscopic and robotic surgery, enhancing surgeons' accuracy by highlighting the dissection planes characterized by connective tissue.

Discover Reeva FT: Revolutionizing Wound Covering for Healthcare Pros

Reeva FT is offered in a variety of sizes: 2x2 cm, 2x3 cm, 4x4 cm, 4x6 cm, 4x8 cm, and 10x15 cm. Reeva FT is confirmed by the FDA Tissue Reference Group to meet the criteria for regulation solely under Section 361 of the PHS Act as defined in 21 CFR Part 1271.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

By using this website you agree to accept Medical Device News Magazine Privacy Policy